Loring Wolcott & Coolidge Fiduciary Advisors LLP Johnson & Johnson Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $10.4 Billion
  • Q1 2024

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 307,290 shares of JNJ stock, worth $45.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
307,290
Previous 328,922 6.58%
Holding current value
$45.2 Million
Previous $51.6 Million 5.71%
% of portfolio
0.47%
Previous 0.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$155.22 - $162.74 $3.36 Million - $3.52 Million
-21,632 Reduced 6.58%
307,290 $48.6 Million
Q4 2023

Feb 01, 2024
SELL
$145.6 - $158.88 $1.83 Million - $1.99 Million
-12,549 Reduced 3.67%
328,922 $51.6 Million
Q3 2023

Nov 03, 2023
SELL
$155.75 - $174.48 $3.95 Million - $4.42 Million
-25,335 Reduced 6.91%
341,471 $53.2 Million
Q2 2023

Aug 01, 2023
BUY
$154.35 - $166.11 $82,114 - $88,370
532 Added 0.15%
366,806 $60.7 Million
Q1 2023

May 02, 2023
BUY
$151.05 - $180.26 $850,864 - $1.02 Million
5,633 Added 1.56%
366,274 $56.8 Million
Q4 2022

Mar 02, 2023
BUY
$160.2 - $179.79 $49,662 - $55,734
310 Added 0.09%
360,641 $63.7 Million
Q4 2022

Feb 14, 2023
SELL
$160.2 - $179.79 $181,827 - $204,061
-1,135 Reduced 0.31%
360,331 $60.6 Million
Q3 2022

Oct 25, 2022
SELL
$161.33 - $179.52 $49,044 - $54,574
-304 Reduced 0.08%
361,466 $59 Million
Q2 2022

Jul 26, 2022
BUY
$168.19 - $186.01 $10,764 - $11,904
64 Added 0.02%
361,770 $64.2 Million
Q1 2022

Apr 13, 2022
SELL
$158.14 - $179.59 $1.6 Million - $1.82 Million
-10,111 Reduced 2.72%
361,706 $64.1 Million
Q4 2021

Feb 14, 2022
SELL
$155.93 - $173.01 $437,851 - $485,812
-2,808 Reduced 0.75%
371,817 $63.6 Million
Q3 2021

Nov 12, 2021
SELL
$161.5 - $179.47 $802,009 - $891,248
-4,966 Reduced 1.31%
374,625 $60.5 Million
Q2 2021

Aug 13, 2021
SELL
$159.48 - $171.07 $20,732 - $22,239
-130 Reduced 0.03%
379,591 $62.5 Million
Q1 2021

Apr 14, 2021
SELL
$153.07 - $170.48 $813,720 - $906,271
-5,316 Reduced 1.38%
379,721 $62.4 Million
Q4 2020

Jan 14, 2021
SELL
$137.11 - $157.38 $560,505 - $643,369
-4,088 Reduced 1.05%
385,037 $60.6 Million
Q3 2020

Oct 15, 2020
SELL
$140.38 - $153.83 $1.34 Million - $1.46 Million
-9,514 Reduced 2.39%
389,125 $57.9 Million
Q2 2020

Jul 30, 2020
SELL
$128.81 - $155.51 $187,804 - $226,733
-1,458 Reduced 0.36%
398,639 $56.1 Million
Q1 2020

Apr 15, 2020
SELL
$111.14 - $153.99 $3.09 Million - $4.28 Million
-27,765 Reduced 6.49%
400,097 $52.5 Million
Q4 2019

Jan 22, 2020
SELL
$127.5 - $146.44 $6.88 Million - $7.91 Million
-53,983 Reduced 11.2%
427,862 $62.4 Million
Q3 2019

Nov 05, 2019
SELL
$126.95 - $142.14 $2.29 Million - $2.56 Million
-18,030 Reduced 3.61%
481,845 $62.3 Million
Q2 2019

Aug 09, 2019
SELL
$131.15 - $144.24 $1.05 Million - $1.16 Million
-8,036 Reduced 1.58%
499,875 $69.6 Million
Q1 2019

Apr 08, 2019
SELL
$125.72 - $139.79 $419,024 - $465,920
-3,333 Reduced 0.65%
507,911 $71 Million
Q4 2018

Feb 13, 2019
BUY
$122.84 - $147.84 $470,108 - $565,783
3,827 Added 0.75%
511,244 $66 Million
Q3 2018

Oct 31, 2018
SELL
$121.58 - $142.88 $327,414 - $384,775
-2,693 Reduced 0.53%
507,417 $70.1 Million
Q2 2018

Aug 07, 2018
SELL
$119.4 - $131.76 $1.69 Million - $1.87 Million
-14,187 Reduced 2.71%
510,110 $61.9 Million
Q1 2018

Apr 20, 2018
SELL
$125.1 - $148.14 $8.24 Million - $9.76 Million
-65,899 Reduced 11.17%
524,297 $67.2 Million
Q4 2017

Feb 08, 2018
SELL
$131.22 - $143.62 $853,061 - $933,673
-6,501 Reduced 1.09%
590,196 $82.5 Million
Q3 2017

Oct 27, 2017
SELL
$129.47 - $135.38 $96,455 - $100,858
-745 Reduced 0.12%
596,697 $77.6 Million
Q2 2017

Aug 07, 2017
BUY
N/A
597,442
597,442 $0

Others Institutions Holding JNJ

# of Institutions
4,151
Shares Held
1.64B
Call Options Held
15.1M
Put Options Held
12.1M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $384B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email